tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA

Compare Innate Pharma (IPHA) vs. Competitors

Compare
129 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.76
$171.79M
-2.98
3.49%
SELLAS Life Sciences Group
$4.11
$565.50M
-14.50
181.08%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$0.39
$191.10M
-0.88
-66.67%
1 Buy
3 Hold
0 Sell
Hold
Elicio Therapeutics
$8.11
$141.67M
-2.39
-9.08%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$12.82
$280.24M
-0.03
-52.16%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.78
-0.17
-8.72%
SLS
SELLAS Life Sciences Group
4.16
2.67
179.19%
SGMO
Sangamo Biosciences
0.39
-0.85
-68.55%
GNFT
ELTX
Elicio Therapeutics
8.11
-1.11
-12.04%
VOR
Vor Biopharma
12.82
-14.98
-53.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts